Versatile expression system for rapid and stable production of recombinant proteins

被引:29
作者
Cho, MS [1 ]
Yee, H [1 ]
Brown, C [1 ]
Mei, B [1 ]
Mirenda, C [1 ]
Chan, S [1 ]
机构
[1] Bayer Biotechnol, Mol & Cell Biol Proc Sci, Berkeley, CA 94701 USA
关键词
D O I
10.1021/bp0255964
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Previously we reported the development of a novel expression system with Tat/TAR-oriP vectors and HKB11 cell line, which supports high level protein expression (Cho et al. Cytotechnology 2001, 37, 23-30). In the present study, we further demonstrated that HKB11 cells are suitable for high throughput expression (microgram scale) of genomic candidates in transient transfection system for in vitro evaluation of biological functions. HKB11 cells were also shown to support the production of milligram to gram quantities of protein drug candidates for in vivo evaluation of efficacy in various disease models. Stable HKB11 clones secreting high levels of a tissue factor (TF; 40-50 pg/c/d) and B-domain deleted recombinant factor VIII (BDDrFVIII; 5-10 muU/c/d) were derived under serum-free conditions. The specific productivity for these two proteins from the HKB11 cells was 10-fold greater than those from CHO cells derived under the similar conditions. In conclusion, we have demonstrated that the HKB11 cell line is well-suited for transient and long-term production of recombinant proteins.
引用
收藏
页码:229 / 232
页数:4
相关论文
共 13 条
[1]  
ALT FW, 1978, J BIOL CHEM, V253, P1357
[2]   Recombinant protein expression for therapeutic applications [J].
Andersen, DC ;
Krummen, L .
CURRENT OPINION IN BIOTECHNOLOGY, 2002, 13 (02) :117-123
[3]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[4]   Therapeutic antibody expression technology [J].
Chadd, HE ;
Chamow, SM .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :188-194
[5]  
CHAN SY, 1991, SEMIN HEMATOL, V28, P10
[6]   Establishment of a human somatic hybrid cell line for recombinant protein production [J].
Cho, MS ;
Yee, H ;
Chan, S .
JOURNAL OF BIOMEDICAL SCIENCE, 2002, 9 (06) :631-638
[7]   An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells [J].
Cho, MS ;
Yee, H ;
Brown, C ;
Jeang, KT ;
Chan, S .
CYTOTECHNOLOGY, 2001, 37 (01) :23-30
[8]   Industrial choices for protein production by large-scale cell culture [J].
Chu, L ;
Robinson, DK .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :180-187
[9]   High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells [J].
Durocher, Y ;
Perret, S ;
Kamen, A .
NUCLEIC ACIDS RESEARCH, 2002, 30 (02) :E9
[10]   CONSTRUCTION AND CHARACTERIZATION OF AN ACTIVE FACTOR-VIII VARIANT LACKING THE CENTRAL 1/3 OF THE MOLECULE [J].
EATON, DL ;
WOOD, WI ;
EATON, D ;
HASS, PE ;
HOLLINGSHEAD, P ;
WION, K ;
MATHER, J ;
LAWN, RM ;
VEHAR, GA ;
GORMAN, C .
BIOCHEMISTRY, 1986, 25 (26) :8343-8347